Pay in 4 interest-free payments of $31.50 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
such as tumor necrosis factor-alpha (TNF-alpha) and interleukin-1 beta (IL-1 beta)
5-dihydro-1H-pyrrol-3-yl)-1H-indol-1-yl)propyl carbamimidothioate methanesulfonate
Smiles: CN(C)CC(CNC(=O)COC1=CC(=CC=C1)[C@@H](CCC1=CC(OC)=C(C=C1)OC)OC(=O)[C@@H]1CCCCN1C(=O)[C@@H](CC)C1=CC(OC)=C(OC)C(=C1)OC)CNC(=O)COC1=CC(=CC=C1)[C@@H](CCC1=CC(OC)=C(C=C1)OC)OC(=O)[C@@H]1CCCCN1C(=O)[C@@H](CC)C1=CC(OC)=C(OC)C(=C1)OC
29(40)36(5)35(3)4)19-22-12-7-6-8-13-22/h6-10
Vandetanib was the first drug to be approved by FDA (April 2011) for treatment of late-stage (metastatic) medullary thyroid cancer in adult patients who are ineligible for surgery
Miglustat 0307 such as tumor necrosis factor-alphaMiglustat is a glucosylceramide synthase inhibitor. Product information CAS Number: 72599 27 0 Molecular Weight: 219. 28 Formula: C10H21NO4 Chemical Name: (2R,3R,4R,5S) 1 butyl 2 (hydroxymethyl)piperidine 3,4,5 triol Smiles: CCCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO InChiKey: UQRORFVVSGFNRO UTINFBMNSA N InChi: InChI=1S C10H21NO4 c1 2 3 4 11 5 8(13)10(15)9(14)7(11)6 12 h7 10,12 15H,2 6H2,1H3 t7 ,8+,9 ,10 m1 s1 Technical Data Appearance: Solid Power
US$ 120.00
US$ 85.00
US$ 120.00
US$ 185.00
US$ 150.00
US$ 180.00
US$ 18.11
US$ 38.00
US$ 68.00
US$ 27.83
US$ 180.00